相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation
Jian Jin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Brexpiprazole: A Review in Schizophrenia
James E. Frampton
DRUGS (2019)
Multi-Target Approach for Drug Discovery against Schizophrenia
Magda Kondej et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics
Xudong Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
David A. Sykes et al.
NATURE COMMUNICATIONS (2017)
Classics in Chemical Neuroscience: Aripiprazole
Austen B. Casey et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Brexpiprazole for the treatment of schizophrenia
Anne Yee
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Brexpiprazole for the treatment of schizophrenia
Anne Yee
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Attenuation of MK-801-Induced Behavioral Perseveration by Typical and Atypical Antipsychotic Pretreatment in Rats
Erin W. Tuplin et al.
BEHAVIORAL NEUROSCIENCE (2015)
Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development
Michael A. Letavic et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Schizophrenia
Rene S. Kahn et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Effects of central activation of serotonin 5-HT2A/2C or dopamine D-2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test
Min Feng et al.
PSYCHOPHARMACOLOGY (2015)
The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia
Lakshmi Rajagopal et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics
Yin Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
D1 receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats
Masakuni Horiguchi et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain
Meng He et al.
CNS DRUGS (2013)
Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics
Yin Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
Silvio Caccia et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2013)
Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Joanne Y. T. Leung et al.
PHARMACOLOGY & THERAPEUTICS (2012)
The histamine H3 receptor: from discovery to clinical trials with pitolisant
Jean-Charles Schwartz
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The role of serotonin receptors in the action of atypical antipsychotic drugs
H. Y. Meltzer et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Conditioned Avoidance Response in the Development of New Antipsychotics
M-L. G. Wadenberg
CURRENT PHARMACEUTICAL DESIGN (2010)
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Richard B. Mailman et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation
Emanuel Raschi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
The role of 5-HT1A receptors in learning and memory
Sven Ove Ogren et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
Neil Upton et al.
NEUROTHERAPEUTICS (2008)
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
H. A. Nasrallah
MOLECULAR PSYCHIATRY (2008)
Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia:: A triple tracer PET study
David Mamo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors:: Comparing aripiprazole to other antipsychotics in animal models
Sridhar Natesan et al.
NEUROPSYCHOPHARMACOLOGY (2006)
QT prolongation through hERG K+ channel blockade:: Current knowledge and strategies for the early prediction during drug development
M Recanatini et al.
MEDICINAL RESEARCH REVIEWS (2005)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
New antipsychotics and schizophrenia: A review on efficacy and side effects
A Serretti et al.
CURRENT MEDICINAL CHEMISTRY (2004)
5-HT2C receptor antagonists:: Potential in schizophrenia
MD Wood et al.
DRUG DEVELOPMENT RESEARCH (2001)
分享论文
